Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder.

The correction notice in the journal "Frontiers in Pharmacology" addresses an error in Figure 1 of the article titled "CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder." The chemical structures in the figure were inaccurate, but this correction does not impact the scientific conclusions of the article. The authors have provided the corrected Figure 1, and the original article has been updated accordingly. [Extracted from the article]